Found 19 matching trials
Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients.
PHASE1Spinal Cord Injury (SCI) is a devastating condition that leads to permanent...
Location
Cell Therapy Center, University of Jordan
A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union
PHASE3ORTHOUNION is a multi-centre, open, comparative, randomized, clinical trial...
Location
CHU Clermont-Ferrand
Mesenchymal Stromal Cell Therapy in Renal Recipients
PHASE2This study will test the hypothesis that MSCs in combination with Everolimu...
Location
Leiden University Medical Center
Autologous BM-MSC Transplantation in Combination With Platelet Lysate (PL) for Nonunion Treatment
PHASE2Nonunion of long bones would occur in almost 10% of fractures and because o...
Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease
PHASE1Kienböck's disease is characterized by avascular necrosis of the lunate wri...
Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis
PHASE3This is a study to assess safety and preliminary clinical activity of treat...
Location
Institute of Bio-Stem Cell Rehabilitation
BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients
PHASE1The purpose of this study is to evaluate the preliminary safety and efficac...
Location
Van Hanh General Hospital
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
PHASE1This is a clinical trial for chronic pancreatitis (CP) patients undergoing ...
Location
Medical University of South Carolina
The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans
PHASE1Autologous bone marrow-derived mesenchymal cells will be injected into pati...
Status
Active Not Recruiting
Location
Cell Therapy Center, University of Jordan
Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD
PHASE2ACTIVE is a phase II B efficacy monocenter, prospective, randomized, contro...
Location
Campus Bio-Medico University of Rome